HERON to present at ISPOR meeting this May
We are pleased announce that HERON will be exhibiting and presenting at the 14th Annual International Meeting of ISPOR, the International Society for Pharmacoeconomics and Outcomes Research. The meeting will be held on 16-20 May 2009 and will be attended by several HERON staff from the US, UK and India. Over the course of the conference, we will be presenting 1 workshop and 14 posters.
The workshop will focus on the importance of updating systematic reviews, as well as discussing the many challenges faced by researchers when attempting to add new data to a previous systematic review. Practical solutions to these difficulties will also be discussed. The workshop will be lead by Dr Samuel Stoddart (HERON's Technical Lead for systematic reviews) and Melanie Plested (Senior Analyst) in collaboration with Dr Alexander Tsertsvadze, an expert in systematic review methodology, currently working with the Clinical Epidemiology Program, Ottawa Health Research Institute, Ontario.Conference programme
Workshop –Wednesday May 20th 8.30-9.30 am:
Updating Systematic Reviews – their importance and techniques for updating. Alexander Tsertsvadze, Samuel Stoddart, Melanie Plested.
Poster session I—Monday 18th May
PMC8: Systematic review reliability: efficacy of two independent reviewers and two step reviews. Pietri G and Muston D
PMC23: Where is the current focus of health economics? An investigation into the published literature within three key health economics journals. Samuels E, Phiri D.
PMC32: Relevance of conference abstracts and hand-searching in systematic reviews. Karia R, Zwaferink H, Malik M.
PMC46: Review and chronology of smoking cessation models. Fisher M, Muston D, Knight C.
PMC88: An exploratory analysis of reasons behind premature termination of randomized controlled trials. Dimri S, Ubhadiya BS, Singh N, Narvilkar P, Bhanderi M.
PMC91: Reporting quality of double-blind randomized controlled trials and its association with the funding agency. Agrawal R, Dimri S, Ubhadiya BS, Narvilkar P, Bhanderi M.
PCN59: Incidence rate and burden of illness of cervical cancer in United States of America. Srivastava K, Rai MK, Siddiqui MK, Goyal R, Chawla A, Takyar S, Sharma S.
Poster session II – Tuesday 19th May
PHP8: A comparison of policies on paediatric dosing guidelines and indications between the United States and Europe. Nixon F, Chan M
PHP82: Use of indirect comparison in HTA submissions. Glassup F, Modha R, Muston D, Kerrigan J, Misra A, Williams R.
PHP84: A comparison of reasons for recommendation and rejection across four health technology appraisal systems categorised by disease. Plested M, Karia R, Samuels E.
PHP87: The impact of the submission sequence – which appraising body to submit to first? Karia R, Plested M.
PIN5: Pharmacogenomics: Applicability in Antiretro Viral Therapy (ART) in HIV Patients. Goyal R, Rai MK, Chawla A, Siddiqui MK, Srivastava K.
PIN32: Pharmacoeconomic Relevance of Antiretro Viral Therapy (ART) in Low and Middle Income Countries. Rai MK, Goyal R, Srivastava K, Siddiqui MK, Chawla A, Joshi B, Sehgal M.
PDB5: Type 2 diabetes – influence of lifestyle change? Arora A, Aneja G, Shukla H, Alnwick K.